GE Healthcare and Cellular Dynamics International Agree to Sublicense for Cellular Assay Patents
Wednesday, December 19, 2012
Companies have announced that GE Healthcare has licensed CDI to develop, manufacture and sell cellular assays and models derived from iPS cells for use in drug discovery and toxicity screening.

Optibrium and Digital Chemistry Announce Technology Collaboration
Friday, December 14, 2012
Integration of bioisostere database with automatic application and prioritisation will guide the identification of successful, novel, high quality compounds in drug discovery.

4SC Announces Positive Interim Results from Clinical Phase I/II SHORE Study
Thursday, December 13, 2012
Phase II part of study planned to start soon in 2013.

Lilly Provides Update on Next Steps for Solanezumab
Thursday, December 13, 2012
Eli Lilly and Company provided an update on the next steps planned for solanezumab, its Phase 3 monoclonal antibody being studied as a potential therapy for patients with mild Alzheimer's disease.

DOW Chemical at the World Drug Delivery & Formulation Summit 2013
Monday, December 10, 2012
The pharmaceutical industry is experiencing a massive paradigm shift as the era of the highly profitable blockbusters comes to a close.

Hovione and Solvias Announce a Collaboration
Friday, November 30, 2012
Collaboration to provide for improved drug solubility.

Drug Developed in U.K. to Treat Solid Tumors
Friday, November 30, 2012
Cancer Research U.K.'s Drug Development Office; Cancer Research Technology, and Lorus Therapeutics Inc. have partnered to take a new therapy with the potential to treat solid tumors into its first clinical trial.

Evotec Enters Biology Collaboration with Probiodrug
Thursday, November 29, 2012
Evotec will setup and validate assays to support the pre-clinical and clinical development of QC inhibitors in Alzheimer’s disease.

<<	5 6 7 8 9 10 11	>>
Showing Results 71 - 80 of 2169